You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 24 No. 6, June 1971 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (39)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Subacute Necrotizing Encephalomyelopathy

Effects of Thiamine and Thiamine Propyl Disulfide

Jonathan H. Pincus, MD; Jack R. Cooper, PhD; Yoshinori Itokawa, MD; Maria Gumbinas, MD

Arch Neurol. 1971;24(6):511-517.


Abstract

Treatment of a case of Leigh's disease with (1.5 gm) thiamine and thiamine propyl disulfide (300 mg) was associated with marked improvement in weight and neurologic status and appeared to reverse respiratory failure. For reasons yet unknown, it became increasingly difficult to maintain thiamine levels above 50µg/100 ml in the patient's cerebrospinal fluid (CSF), through blood levels exceeded 1,000µg/100 ml. Remissions correlated with increased CSF thiamine concentrations, exacerbations with low levels. Brain tissue obtained at autopsy had only a slightly elevated total thiamine content (2µg/gm). No thiamine triphosphate was present in pons or cerebellum. Initial successes with this case and several others suggest that there may be some rationale for the use of thiamine and thiamine propyl disulfide in this condition.



Author Affiliations

New Haven, Conn

From the Section of Neurology (Drs. Pincus and Gumbinas) and Department of Pharmacology (Drs. Cooper and Itokawa), Yale University School of Medicine, New Haven, Conn.


Footnotes

Accepted for publication Nov 10, 1970.

Reprint requests to Division of Neurology, Yale University School of Medicine, New Haven, Conn 06510 (Dr. Pincus).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Leigh's Subacute Necrotizing Encephalomyelopathy Manifesting as Spasmus Nutans
Sedwick et al.
Arch Ophthalmol 1984;102:1046-1048.
ABSTRACT  

Leigh Disease: Biochemical Characteristics of the Inhibitor
Murphy et al.
Arch Neurol 1974;31:220-227.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1971 American Medical Association. All Rights Reserved.